BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24879409)

  • 1. Susceptibility-weighted imaging for the noncontrast evaluation of hepatocellular carcinoma: a prospective study with histopathologic correlation.
    Chen W; DelProposto Z; Liu W; Kassir M; Wang Z; Zhao J; Xie B; Wen Y; Wang J; Hu J
    PLoS One; 2014; 9(5):e98303. PubMed ID: 24879409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing venous vasculatures of hepatocellular carcinoma using a multi-breath-hold two-dimensional susceptibility weighted imaging.
    Chang SX; Li GW; Chen Y; Bao H; Zhou L; Yuan J; Wu DM; Dai YM
    PLoS One; 2013; 8(6):e65895. PubMed ID: 23799060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a 2D multibreath-hold susceptibility-weighted imaging to visualize intratumoral hemorrhage of hepatocellular carcinoma at 3T MRI: correlation with pathology.
    Li RK; Zeng MS; Rao SX; Qiang JW; Dai YM; Ji Y; Chen CZ; Renate J
    J Magn Reson Imaging; 2012 Oct; 36(4):900-6. PubMed ID: 22744981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pseudocapsule in hepatocellular carcinoma: correlation between dynamic MR imaging and pathology.
    Grazioli L; Olivetti L; Fugazzola C; Benetti A; Stanga C; Dettori E; Gallo C; Matricardi L; Giacobbe A; Chiesa A
    Eur Radiol; 1999; 9(1):62-7. PubMed ID: 9933382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing hepatocellular carcinoma using multi-breath-hold two-dimensional susceptibility-weighted imaging: comparison to conventional liver MRI.
    Tao R; Zhang J; Dai Y; You Z; Fan Y; Cui J; Wang J
    Clin Radiol; 2012 Dec; 67(12):e91-7. PubMed ID: 22981726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T2-weighted and T1-weighted dynamic superparamagnetic iron oxide (ferucarbotran) enhanced MRI of hepatocellular carcinoma and hyperplastic nodules.
    Chen RC; Lii JM; Chou CT; Chang TA; Chen WT; Li CS; Tu HY
    J Formos Med Assoc; 2008 Oct; 107(10):798-805. PubMed ID: 18926947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
    Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
    World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance imaging appearance of well-differentiated hepatocellular carcinoma.
    Li CS; Chen RC; Lii JM; Chen WT; Shih LS; Zhang TA; Tu HY
    J Comput Assist Tomogr; 2006; 30(4):597-603. PubMed ID: 16845290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE; Kim SH; Lee SJ; Rhim H
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mosaic pattern of encapsulated hepatocellular carcinoma: correlation of magnetic resonance imaging and pathology.
    Choi BI; Lee GK; Kim ST; Han MC
    Gastrointest Radiol; 1990; 15(3):238-40. PubMed ID: 2160392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phased array breath-hold versus non-breath-hold MR imaging of focal liver lesions: a prospective comparative study.
    Yamashita Y; Yamamoto H; Namimoto T; Abe Y; Takahashi M
    J Magn Reson Imaging; 1997; 7(2):292-7. PubMed ID: 9090580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small hepatocellular carcinoma: relationship of signal intensity to histopathologic findings and metal content of the tumor and surrounding hepatic parenchyma.
    Ebara M; Fukuda H; Kojima Y; Morimoto N; Yoshikawa M; Sugiura N; Satoh T; Kondo F; Yukawa M; Matsumoto T; Saisho H
    Radiology; 1999 Jan; 210(1):81-8. PubMed ID: 9885591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small hepatocellular carcinoma on magnetic resonance imaging. Relation of signal intensity to angiographic and clinicopathologic findings.
    Honda H; Kaneko K; Maeda T; Kuroiwa T; Fukuya T; Yoshimitsu K; Irie H; Aibe H; Takenaka K; Masuda K
    Invest Radiol; 1997 Mar; 32(3):161-8. PubMed ID: 9055129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.
    Kovac JD; Ivanovic A; Milovanovic T; Micev M; Alessandrino F; Gore RM
    Radiol Oncol; 2021 Jan; 55(2):130-143. PubMed ID: 33544992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K; Kuroki Y; Tsukamoto T; Nakajima H; Mori K; Minami M
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.